Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
36%
Blood Coagulation Factor
9%
Candidate Gene
9%
Carboxylation
9%
Cytochrome P450
9%
Dose Response
9%
Drug Effect
9%
Drug Interaction
9%
Drug Therapy
18%
Enzyme
9%
Gene Interaction
9%
Genetic Divergence
9%
Genetic Risk
18%
Genetics
100%
Genomics
18%
Human Study
9%
Isoform
9%
Metabolic Pathway
9%
Oxidoreductase
9%
Pharmacogenetics
63%
Pharmacogenomics
9%
Prospective Study
9%
Reductase
9%
Structure Activity Relationship
9%
Targeted Therapy
27%
Trastuzumab
9%
Vitamin K Epoxide Reductase
63%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
16%
Atrial Fibrillation
16%
Chronic Disease
8%
Genetic Risk
8%
Pharmacogenetics
32%
Pharmacotherapy
8%
Therapeutic Window
8%
Thromboembolism
20%
Venous Thromboembolism
8%
Vitamin K Epoxide Reductase
28%
Warfarin
100%